Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Parkinson's Disease: Overview01:15

Parkinson's Disease: Overview

2.5K
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
2.5K
Parkinson's Disease: Treatment01:24

Parkinson's Disease: Treatment

1.4K
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
1.4K
Neural Regulation01:37

Neural Regulation

45.2K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
45.2K
Brainstem01:19

Brainstem

8.5K
The brainstem, located inferior to the brain and superior to the spinal cord, serves as a bridge between the cerebrum and the spinal cord. It plays a vital role in relaying information and controlling critical life functions. It comprises three primary regions: the midbrain, pons, and medulla oblongata.
The Midbrain
The midbrain is located beneath the diencephalon and connects the cerebrum with the lower parts of the brain. The cerebral peduncles are prominent midbrain structures that house the...
8.5K
Lysosomal Hydrolases01:22

Lysosomal Hydrolases

4.8K
Lysosomes are the site for the degradation of macromolecules and biological polymers released during membrane trafficking events such as secretory, endocytic, autophagic, and phagocytic pathways. The membrane-enclosed area of the lysosome, called the lumen, contains hydrolytic enzymes active in an acidic environment. These acid hydrolases are functional at a pH between 4.5 and 5 and are involved in cellular processes such as cell signaling, energy metabolism, restoration of the plasma membrane,...
4.8K
Protein and Protein Structure02:15

Protein and Protein Structure

93.5K
Proteins are one of the most abundant organic molecules in living systems and have the most diverse range of functions of all macromolecules. Proteins may be structural, regulatory, contractile, or protective. They may serve in transport, storage, or membranes; or they may be toxins or enzymes. Their structures, like their functions, vary greatly. They are all, however, amino acid polymers arranged in a linear sequence.
A protein's shape is critical to its function. For example, an enzyme...
93.5K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The divergent LARP1 PAM2 motif adopts a non-canonical conformation for MLLE binding.

Biochemical and biophysical research communications·2026
Same author

The cytoplasmic domains of the CNNM family of transmembrane proteins modulate the ion channel-kinase TRPM7.

The Journal of biological chemistry·2025
Same author

Structure of the phosphocysteine intermediate of the phosphatase of regenerating liver PTP4A1.

The Journal of biological chemistry·2025
Same author

Deep Mutational Scanning of an Engineered High-affinity Ligand of the poly(A) Binding Protein MLLE Domain.

Journal of molecular biology·2025
Same author

A molecular glue for PRKN/parkin.

Autophagy·2024
Same author

Structural basis for the pathogenicity of parkin catalytic domain mutants.

The Journal of biological chemistry·2024

Related Experiment Video

Updated: Apr 17, 2026

Author Spotlight: Establishing a New Fluorescence-Based Protocol for In Vivo Mitochondrial Morphology Analysis in Parkinson's Disease
06:07

Author Spotlight: Establishing a New Fluorescence-Based Protocol for In Vivo Mitochondrial Morphology Analysis in Parkinson's Disease

Published on: June 23, 2023

2.4K

Parkin structure and function.

Marjan Seirafi1, Guennadi Kozlov1, Kalle Gehring1

  • 1Department of Biochemistry and the Groupe de Recherche axé sur la Structure des Protéines, McGill University, Montréal, Québec, Canada.

The FEBS Journal
|February 26, 2015
PubMed
Summary

Mutations in parkin and PINK1 genes cause Parkinson's disease. This review details how these proteins regulate mitochondrial quality control and mitophagy, offering insights for drug discovery.

Keywords:
PINK1mitophagyparkinubiquitinubiquitination

More Related Videos

The Use of Primary Human Fibroblasts for Monitoring Mitochondrial Phenotypes in the Field of Parkinson's Disease
15:09

The Use of Primary Human Fibroblasts for Monitoring Mitochondrial Phenotypes in the Field of Parkinson's Disease

Published on: October 3, 2012

17.6K
Primary Culture of Mouse Dopaminergic Neurons
11:58

Primary Culture of Mouse Dopaminergic Neurons

Published on: September 8, 2014

40.0K

Related Experiment Videos

Last Updated: Apr 17, 2026

Author Spotlight: Establishing a New Fluorescence-Based Protocol for In Vivo Mitochondrial Morphology Analysis in Parkinson's Disease
06:07

Author Spotlight: Establishing a New Fluorescence-Based Protocol for In Vivo Mitochondrial Morphology Analysis in Parkinson's Disease

Published on: June 23, 2023

2.4K
The Use of Primary Human Fibroblasts for Monitoring Mitochondrial Phenotypes in the Field of Parkinson's Disease
15:09

The Use of Primary Human Fibroblasts for Monitoring Mitochondrial Phenotypes in the Field of Parkinson's Disease

Published on: October 3, 2012

17.6K
Primary Culture of Mouse Dopaminergic Neurons
11:58

Primary Culture of Mouse Dopaminergic Neurons

Published on: September 8, 2014

40.0K

Area of Science:

  • Neuroscience
  • Molecular Biology
  • Genetics

Background:

  • Mutations in parkin and PINK1 genes are primary causes of autosomal recessive Parkinson's disease.
  • Parkin (E3 ubiquitin ligase) and PINK1 (serine/threonine kinase) are neuroprotective proteins.
  • These proteins function collaboratively in mitochondrial quality control.

Purpose of the Study:

  • To review the structure, autoinhibition, and ubiquitin ligase function of parkin.
  • To present a model for parkin's role in mitophagy.
  • To discuss other parkin functions and drug discovery avenues.

Main Methods:

  • Literature review of parkin and PINK1.
  • Analysis of parkin structure and function.
  • Model development for parkin-mediated mitophagy.

Main Results:

  • Parkin's structure and autoinhibition mechanisms are detailed.
  • A model for parkin recruitment and activation in mitophagy is proposed.
  • Parkin's critical role in clearing damaged mitochondria is highlighted.

Conclusions:

  • Parkin and PINK1 are crucial for mitochondrial quality control and mitophagy.
  • Understanding parkin's activation is key to developing Parkinson's disease therapies.
  • Further research into this pathway may yield novel therapeutic strategies.